Filtered Listing Testing

National Glaucoma Research
May 22, 2024
BrightFocus Foundation

Global brain and vision research nonprofit BrightFocus Foundation and the Helen Keller Foundation for Research and Education have named ophthalmologist José Cunha-Vaz, MD, PhD, the recipient of the 2024 Helen Keller Prize for Vision Research in recognition of his immense contributions to the field.

May 10, 2024
BrightFocus Foundation

On May 6, BrightFocus Foundation recognized five vision scientists for their research focused on preventing, treating, and curing macular degeneration and glaucoma during the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO).

May 9, 2024
BrightFocus Foundation

Global nonprofit BrightFocus Foundation announces $10 million in new Alzheimer’s disease, macular degeneration, and glaucoma research grant funding—age-related diseases with no cure that affect more than 335 million people worldwide.

Apr 23, 2024
BrightFocus Foundation

BrightFocus Foundation, a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma, has welcomed Jon Walsh as its new Senior Vice President, Finance and Administration. 

Apr 2, 2024
Alzheimer's Disease Research

A promising new treatment for individuals suffering from stroke, concussion, and traumatic brain injury, known risk factors for dementia, has received approval from the U.S. Food & Drug Administration to move into Phase 2 clinical trials. Learn more.

Mar 28, 2024
Alzheimer's Disease Research

Learn how our funded scientists are advancing new ways of diagnosing Alzheimer’s disease earlier and more accurately.

Mar 28, 2024
Alzheimer's Disease Research

Alzheimer’s Disease Research, a BrightFocus Foundation program, joined over 4,500 scientists, physicians, and industry leaders from 70 countries at the annual International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD) in Lisbon, Portugal. Read our key takeaways.

 

Mar 11, 2024
Alzheimer's Disease Research

The company behind the first-of-its-kind blood-based screening test for Alzheimer’s disease—rooted in pivotal early BrightFocus support—has received a $15 million investment that will broaden access to the blood test for patients and doctors.

Mar 11, 2024
Alzheimer's Disease Research

A National Institute on Aging senior investigator breaks down amyloid trials: what went wrong and what must come next.

Mar 6, 2024